Hereditary angioedema associated with heterozygous factor V Leiden mutation in a patient with purpura fulminans

International Archives of Allergy and Immunology

Volumn 142, Issue 2, 2007, Pages 175-178

  Celikel, S ^a   Buyukasik, Y ^a   Karakaya, G ^a   Kalyoncu, A F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Factor V Leiden mutation; Hereditary angioedema; Purpura fulminans; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; COMPLEMENT COMPONENT C1S INHIBITOR; DESOGESTREL PLUS ETHINYLESTRADIOL; PROTEIN C;

ADULT; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EMERGENCY WARD; FEMALE; FULMINATING PURPURA; GENE MUTATION; HETEROZYGOTE; HUMAN; LEG EDEMA; MEDICAL EXAMINATION; MENSTRUAL IRREGULARITY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; SKIN NECROSIS; VITAL SIGN;

ADULT; ANGIONEUROTIC EDEMA; FACTOR V; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; POINT MUTATION; PURPURA, SCHOENLEIN-HENOCH;

EID: 33846227819     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096611     Document Type: Article

References (14)

1. Ugochukwu CN, Evangelo F, William JT: Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001;161:2417-2429.
2. Nolan J, Sinclair R: Review of management of purpura fulminans and two case reports. Br J Anaesth 2001;86:581-586.
3. Esmon CT: The impact of the inflammatory response on coagulation. Thromb Res 2004;114:321-327.
4. Yarovaya GA, Blokhina TB, Neshkova EA: Contact system: new concepts on activation mechanisms and bioregulatory functions. Biochemistry (Mosc) 2002;67:13-24.
5. Caliezi C, Wuillemin WA, Zeerleder S, Redondo M, Eisele B, Hack CE: C1-esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. Pharm Rev 2000;52:91-112.
6. Davis AE 3rd: The pathophysiology of hereditary angioedema. Clin Immunol 2005;114:3-9.
7. Gailani D, Broze GJ Jr: Factor XI activation in a revised model of blood coagulation. Science 1991;253:909-912.
8. Di Scipio RG, Kurachi K, Davie EW: Activation of human factor IX (Christmas factor). J Clin Invest 1978;61:1528-1538.
9. Nielsen EW, Morrissey J, Olsen JO, Osterud B: Factor VIIa in patients with C1-inhibitor deficiency. Thromb Haemost 1995;74:1103-1106.
10. Nielsen EW, Johansen HT, Hogasen K, Wuillemin W, Hack CE, Mollnes TE: Activation of the complement, coagulation, fibrinolytic and kallikrein-kinin systems during attacks of hereditary angioedema. Scand J Immunol 1996;44:185-192.
11. Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A: Activation of the coagulation cascade in C1-inhibitor deficiencies. Blood 1997;89:3213-3218.
12. Bork K, Fisher B, Dewald G: Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003;114:294-298.
13. Binkley KE, Davis A: Clinical, biochemical and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000;106:546-550.
14. Perkins W, Downie I, Keefe M, Chisholm M: Cutaneous necrosis in pregnancy secondary to activated protein C resistance in hereditary angioedema. J R Soc Med 1995;88:229P-230P.